Deep and Prolonged Response to Aurora A Kinase Inhibitor and Subsequently to Nivolumab in MYCL1-Driven Small-Cell Lung Cancer: Case Report and Literature Review

Kolla, BC; Racila, E; Patel, MR

CASE REPORTS IN ONCOLOGICAL MEDICINE, 2020; 2020 ():

Abstract

Small-cell lung carcinoma (SCLC) is one of the most aggressive solid tumors, and the prognosis has not improved significantly in 25 years. Despite a r......

Full Text Link